Search
Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.
Insights and Analysis
28 March 2024
This article discusses the most important legal and regulatory considerations for life sciences companies considering a demerger in China. The authors address the challenges and issues...
Insights and Analysis
27 February 2024
This article aims to introduce three recent regulatory updates in China’s life science sector. These updates involve incentives for locally-manufacturing approved foreign drugs,...
News
15 December 2023
Life sciences companies engaged in early development programs face a number of strategic considerations, such as where and how to administer the early stage scientific studies and each...
Insights and Analysis
08 June 2023
For the purpose of providing further detailed guidance on the implementation of the Human Genetic Resources Administration Rules released in May 2019, after years of waiting, China’s...
News
24 May 2023
As part of a new Asia-Pacific (APAC) Life Sciences and Health Care webinar program designed both for companies with commercial interests in APAC and for companies based in the region, Hogan ...
Insights and Analysis
18 May 2023
On March 31, 2023, the Center for Drug Evaluation under the PRC National Medical Products Administration issued the Work Specification for Accelerating the Review of Innovative Drug...
Insights and Analysis
16 February 2023
On May 7, 2021, the National Medical Products Administration released the Good Pharmacovigilance Practices of China, requiring market authorization holders to carry out certain...
Insights and Analysis
20 December 2022
On November 16, 2022, the CDE, together with Hainan MPA and Lecheng Bureau, released the Implementation Measures for Carrying out Real-World Research on Drugs (“2022 Implementation...
Insights and Analysis
10 May 2022
The Ministry of Science and Technology of China has finally issued the draft of Implementation Rules for the Regulations of Human Genetic Resources Administration for public...
